A-Share · Recap
A-Share Market Recap | 2026-10-06 (Tuesday)
Machine-translated from the Chinese original. In case of any discrepancy, the Chinese version prevails.
Single-name entries
This is a reconciliation report — it carries no single-name score table. Recaps are structured around hit-rate reconciliation, theme verification and next-day outlook.
Special statement: A-shares are closed today (10/6) for the National Day holiday (market closed 10/1–10/7, reopening Thursday 10/8). There is no session to review today and no limit-up / northbound / Dragon-Tiger list data. This recap does three things: ① verify the factual base of this morning's pre-market list (in effect the "10/8 first-day-back watch list"); ② track how the holiday market has evolved since the list was published (07:00 this morning) and run a "mid-session reconciliation" of its core calls; ③ lay out the remaining validation checkpoints before the 10/8 open. This morning's pre-market list:
reports/a-share/2026-10-06.md.
0. One-line recap
Day 6 of the A-share holiday break with no domestic tape; the sentiment temperature reads through overseas proxies: the holiday's strongest main line — innovative drugs — keeps getting validated by Hong Kong (10/6 intraday: 康方生物 (Akeso, 09926.HK) +3.87%, 药明康德 H (WuXi AppTec H, 02359.HK) +2.64%, 药明生物 (WuXi Biologics, 02269.HK) +4.15%), the PCB/CCL mapping went vertical on 10/5 and hit high-level divergence on 10/6 (建滔积层板 (Kingboard Laminates, 01888.HK) +11.94% on 10/5 → about −0.63% near the close on 10/6), the oil-tanker headwind materialized (Brent broke below $100 during the holiday), and the pre-market list's biggest risk switch was not triggered — the 10Y UST has fallen from its 5.34% high to about 5.25%–5.31%. The list's calls are mostly right at the holiday's halfway mark; two validation nights remain before the 10/8 open — the evening of 10/6 and all of 10/7 — with the full 10/7 Hong Kong session plus two US sessions as the final observation window.
1. Market Overview
A-shares are closed today. Below are the verified "holiday base" (9/30 close, measured via akshare) and the overseas holiday thermometer:
- 9/30 close (akshare index daily bars, verified one by one): SSE Composite 3842.20(+0.31%), SZSE Component 12887.62(−0.11%), ChiNext 3135.28(−0.23%), STAR 50 1530.01; combined turnover about RMB 1.44 trillion.
- 9/30 limit-up count: the East Money limit-up pool had 52 stocks (matching the pre-market list's "52–56"); the limit-down pool had 9 (the list cited the media caliber of 12–13; see the caliber note below).
- Overseas holiday thermometer (10/6 intraday): Hang Seng Index 24232.56(+0.80%), Hang Seng Tech 4213.56(+0.71%) (Tencent quotes,
15:50 on 10/6); the HSI is still down cumulatively for the holiday (9/30 close 24613 → 10/5 close 24040, about −2.3%, Yahoo HSI history1, Zhitong Finance2), and the 10/6 bounce has not recovered the holiday losses; the US 10-year Treasury yield has fallen from 5.34% (highest since 2002, CLS.cn3) back to about 5.25%–5.31% (TradingEconomics Monday data, Investing.com4), driven mainly by the weak nonfarm payrolls (September +0.029 million) cooling Fed rate-hike expectations; Brent broke below $100/barrel at one point in the 10/6 Asian session (−2.2% intraday, FX6785), and WTI lost $89. - Sentiment temperature: no domestic sentiment mid-holiday. Overseas proxies are neutral-to-positive — the HK bounce and the UST-yield pullback are positives, the oil breakdown is a negative; overall the tape has not departed from the pre-market script of "a structural gap-up, not a broad gap-up."
⚠️ Data-trap log: akshare stock_zt_pool_em(date="20261006") does not error on a non-trading day — it silently falls back to the most recent trading day (9/30), so pulling it naively would mistake the 9/30 limit-up pool for 10/6's. The 9/30 limit-up pool figures in this recap were verified via that date fallback before use. Separately, the 9/30 limit-down count in the EM pool is 9, inconsistent with the media caliber of 12–13 cited in the pre-market list (possibly an ST / Beijing Stock Exchange inclusion difference); this has been flagged in the reconciliation.
2. Pre-Market List Reconciliation
Nature note: this morning's pre-market list is a watch list aimed at 10/8, the first day back (no A-share trading during the holiday window), so there are no individual stock moves to reconcile today. The reconciliation below covers two things: ① verification of the factual base it cited; ② a "half-time validation" of its branch calls against the holiday market so far. True stock-level reconciliation (gains/losses of the 5 recommended stocks, hit rate) must wait for the 10/8 close.
Factual-base verification:
| Verification item | List's figure | Measured/latest figure | Result |
|---|---|---|---|
| 9/30 SSE close | 3842.19(+0.31%) | 3842.20(akshare) | ✅ Match |
| 9/30 SZSE Component / ChiNext | 12887.62(−0.11%)/3135.28(−0.23%) | 12887.62/3135.28(akshare) | ✅ Match |
| 9/30 limit-up count | 52–56 stocks | EM limit-up pool: 52 (akshare) | ✅ Match |
| 9/30 limit-down count | 12–13 stocks | EM limit-down pool: 9 (akshare) | ⚠️ Caliber difference; direction/magnitude consistent (both low) |
| 10/5 Kingboard Laminates gain | "closed up more than 9%" | 10/5 close +11.94% (Futu) | ✅ True and stronger than cited |
| 10Y UST | 5.34%, highest since 2002 | 5.34% was the high around 10/1; on 10/6 it has fallen back to ~5.25%–5.31% | ⚠️ Data point stale, but direction (still high) holds |
| HSI holiday cumulative | ~−2.3% (24613→24040) | 10/5 close 24040 ✅; 10/6 rebound +0.80% to 24232 | ✅ Held as of list-writing time |
Branch-call half-time validation (list published 07:00 this morning; the incremental validation below covers ~9 hours after publication):
| Branch | Pre-market conclusion | 10/6 holiday-market validation | Half-time verdict |
|---|---|---|---|
| Innovative drugs / BD out-licensing + CRO (S) | Strongest holiday main line, likely to continue on 10/8; watch 恒瑞/康希诺 (Hengrui/CanSino) at auction | HK innovative drugs up across the board for a second straight day: 康方生物 (09926.HK) +3.87%, 药明康德 H (02359.HK) +2.64%, 药明生物 (02269.HK) +4.15%, 中国生物制药 (Sino Biopharmaceutical, 01177.HK) +3.96% (Tencent quotes, ~15:50 on 10/6) | ✅ Strengthened; main-line call confirmed by overseas markets |
| Compute hardware / PCB repair (A−) | HK mapping leads; biggest elasticity on 10/8, but "repair or dead-cat bounce depends on auction volume" | 建滔积层板 (01888.HK) +11.94% on 10/5 then −0.63% near the close on 10/6, 建滔集团 (Kingboard Holdings, 00148.HK) −1.22% (Tencent quotes): divergence right after the breakout day | ⚠️ Fits the "mapping leads" framing; chase-high character confirmed; on 10/8 watch auction volume rather than blind gap-ups |
| Oil & gas / tankers (B+) | Most solid logic but an old trend; Brent holding 100 is the validation point | Brent fell below $100 in the 10/6 Asian session (~−2.2%, FX678); 中远海能 H (COSCO Shipping Energy H, 01138.HK) still +2.48% on 10/6 but oil has broken down | ⚠️ Validation point breached; de-weight this branch on 10/8; the list's warning (falling WTI erodes the premium) is playing out |
| Property chain / solid-state batteries / robotics (B+/B) | Sentiment play; watch only, no action | No new catalysts over the holiday; no unusual moves in HK mainland property stocks on 10/6 (southbound detail not yet confirmable) | — No new info; original call stands |
| Macro risk switch (10Y >5.40% triggers de-weighting) | If not triggered, high-valuation branches stay unchanged | 10Y back to ~5.25%–5.31%, far from the trigger line | ✅ Risk unwinding; positive for the 10/8 gap-up structure |
Hit rate: no A-share trading today, so the stock-level hit rate is not applicable; of the 7 fact-base checks, 5 matched and 2 had timing/caliber deviations (both within acceptable range, and the 10Y deviation is on the conservative side = the safer direction). Self-criticism: the list cited the 10Y UST at its early-holiday high without flagging the pullback; a mid-holiday recap should refresh macro risk items in time — "global switch" numbers like this must be rolled over and re-verified daily during a long holiday, not carried over verbatim from the list.
3. Today's Main-Line Validation
There is no A-share main line today. Latest status of the running holiday main lines:
| Branch | Pre-market strength | Latest holiday status (10/6) | Stage | Implication (for 10/8) |
|---|---|---|---|---|
| Innovative drugs / BD out-licensing + CRO | S | HK up across the board two straight days; AZ-Summit/康方 and 恒瑞–Novo Nordisk BD narratives keep building; on 10/6 the whole 药明系/康方/中生制药 complex rallied together | Uptrend continuation (confirmed overseas) | High probability of continuation on 10/8; guard against gap-up profit-taking; watch 恒瑞 (Jiangsu Hengrui Medicine, 600276) / 康希诺 (CanSino Biologics, 688185) at auction |
| PCB/CCL repair | A− | 10/5 HK breakout (建滔 +11.94%) → divergence on 10/6 (−0.63%) | High-level divergence after mapping-driven spike | If the 10/8 gap-up is large, over-extension risk is high; odds rising it should be treated as a dead-cat bounce rather than a repair |
| Tankers / oil & gas | B+ | Brent below 100; risk premium loosening | Trend loosening | Avoid chasing on 10/8; watch how 中远海能 (COSCO Shipping Energy, 600026) absorbs the pullback |
| Others (property / solid-state / robotics / film) | B | No holiday catalysts | Stalled | Keep "watch only" |
Did the pre-market list call the strongest main line correctly? It called "innovative drugs as the holiday's strongest main line," and HK has kept validating that call halfway through the holiday — correct. It also listed the PCB repair as "the biggest elasticity direction," which HK validated on 10/5, but the 10/6 divergence shows the flip side of that "elasticity": high-level relay risk. What the pre-market list missed: no major surprise main line; note the Nobel Prize in Physics at 17:45 on 10/6 (condensed matter / quantum anomalous Hall effect heavily tipped, with Xue Qikun a hot candidate) — if it goes to a quantum-materials direction, quantum-tech / cryogenic-superconductivity concepts could get a brief pop on 10/7–10/8, an event-type variable the pre-market list did not cover (Shanghai Observer7, ScienceNet8).
4. Limit-Up Tiers / Height Boards
No trading today; tiers are as of the 9/30 close (akshare East Money limit-up pool, 52 names): the highest board is 新华传媒 (Xinhua Media, 600825, Shanghai main board) at 7 consecutive limit-ups (M&A restructuring, a pure-sentiment height board, with about RMB 1.99 billion in sealing funds); the 3-board tier has 深物业 A (Shenzhen Property A, 000011, Shenzhen main board, property-sentiment benchmark), 九阳股份 (Joyoung, 002242, Shenzhen main board), and 时代万恒 (Times Wanheng, 600241, Shanghai main board); the 2-board tier includes 传艺科技 (Chuanyi Technology, 002866, Shenzhen main board); 20CM first limit-up boards include pharma names like 康希诺 (CanSino Biologics, 688185, STAR Market) and 泰诺麦博-U (Trinomab-U, 688806, STAR Market) (STAR Market is ±20%). On the broken-board/ebb side: 澳弘电子 (Aohong Electronics, 605058, Shanghai main board) and 协和电子 (Xiehe Electronics, 605258, Shanghai main board) hit limit-down on 9/30 — the instigators of the PCB ebb, and a reverse anchor for judging the quality of any PCB repair on 10/8. Watch for 10/8: with no A-share trading for the 8-day holiday, the consecutive-board genes of the pre-holiday tiers will almost certainly snap (pure-sentiment height boards like 新华传媒 (600825), already flagged by the list as a "sentiment thermometer," would cool short-term sentiment overall if they get nuked straight at the open on 10/8); tiers rebuild from first limit-up boards starting 10/8, and pre-holiday height boards serve only as a sentiment reference, not a relay basis.
5. Money Flows
A-shares are closed today: no northbound flows, no Dragon-Tiger data. Available holiday money signals (as of ~15:50 on 10/6, Tencent quotes): southbound flow detail via Stock Connect is not yet confirmable; judging from individual stock behavior, holiday money clearly favors innovative-drug H shares (药明生物 (WuXi Biologics, 02269.HK), 康方生物 (Akeso, 09926.HK), 中国生物制药 (Sino Biopharmaceutical, 01177.HK) rallying on rising volume for consecutive days) and core HK weights (腾讯控股 (Tencent, 00700.HK) +1.18%); for PCB/CCL it is a "profit-taking the day after the breakout" rhythm; for tankers (中远海能 H +2.48%) it is inertial money from before the oil breakdown — the first reading of northbound/main-fund net inflows after the 10/8 A-share open matters more than any holiday inference, and must be measured then.
6. Outlook (Remaining Validation Window Before the 10/8 Open)
① Base tone: keep the pre-market list's "a structural gap-up on 10/8, not a broad gap-up." Evidence at the holiday's halfway mark leans positive (innovative-drug main line confirmed overseas + 10Y UST far from the 5.40% trigger line); chase-high risk rises for tankers and PCB.
② Remaining validation points for the evening of 10/6 – 10/7 (chronological):
- 17:45 on 10/6, Nobel Prize in Physics (quantum materials / condensed matter hotly tipped): if it lands, quantum-tech concepts could ferment on 10/7 — a new event variable (Shanghai Observer7);
- The two US sessions on 10/6–10/7: if the Nasdaq (record closing high 27477.31 on 10/5) turns down, or the 10Y climbs back toward 5.40%, the list's §0 de-weighting condition triggers and high-valuation branches (high-PE innovative drugs, PCB) get de-weighted across the board;
- All of 10/7 in Hong Kong: the last trading day of the holiday and the most direct guide for the 10/8 A-share auction — watch whether innovative-drug H shares can rise a third straight day, whether 建滔积层板 (Kingboard Laminates, 01888.HK) repairs after its divergence, and whether the HSI can reclaim 24400 (half of the holiday decline);
- 17:45 on 10/7, Nobel Prize in Chemistry: the list already flagged it as a concept-stimulation item; expect a one-day pop.
③ Key items for 10/8 (carried over unchanged from list §8/§9): innovative-drug auction strength (恒瑞医药 (Jiangsu Hengrui Medicine, 600276) gap-up ≤3% is healthy; 康希诺 (CanSino Biologics, 688185) gap-up above 8% — guard against profit-taking); whether the PCB auction has ≥3 stocks broadly green with volume (生益科技 (Shengyi Technology, 600183) gap-up ≤3% counts as healthy); and the opening absorption of property-sentiment benchmark 深物业 A (Shenzhen Property A, 000011).
④ Avoid on 10/8: chasing tankers (Brent has broken 100; the validation point for 中远海能 (COSCO Shipping Energy, 600026) is lost); over-extended PCB mappings gapping up more than 5% (pure A/H mapping names like 景旺电子 (Kinwong Electronic, 603228) get hit first); pre-holiday pure-sentiment height boards (high-level relay in 新华传媒 (Xinhua Media, 600825) and 深物业 A (000011)).
⑤ Input notes for tomorrow morning's (10/8) pre-market list: ① refresh the 10Y UST and the two US sessions, and update the §0 macro switch status; ② downgrade the tanker branch from neutral watch to avoid-chasing, restoring it only if Brent reclaims 100; ③ add the 10/7 HK close readings (innovative drugs third straight day / Kingboard repair / HSI level) as auction guidance; ④ if the physics prize goes to a quantum-materials direction, add a single C-grade "quantum tech" event branch — do not upgrade it; ⑤ recommend unifying the 9/30 limit-down caliber in the list to the EM limit-up pool caliber, with a note.
⚠️ Risk warning: this recap is merely a post-close (mid-holiday) information summary for observation and does not constitute investment advice. A-shares are closed today; A-share figures herein are as of the 9/30 close, and HK/overseas figures are 10/6 intraday readings — timing or caliber differences may exist. Please refer to exchange/company disclosures; do not use this directly as a trading basis.
Sources8
Every external link cited in the body, numbered in order of appearance. · 7 domains
- 1Yahoo HSI historyhk.finance.yahoo.com
- 2Zhitong Financem.zhitongcaijing.com
- 3CLS.cnm.cls.cn
- 4Investing.comcn.investing.com
- 5FX678quote.fx678.com
- 6FX678quote.fx678.com
- 7Shanghai Observershobserver.com
- 8ScienceNetnews.sciencenet.cn